BIOPROGNOSIS
"BIOPROGNOSIS" is a trademark owned by Renalytix AI, Inc., filed at the WIPO on January 11, 2022. It is on file and covers classes 5, 10, 42 and 44.
- Status
- Mixed
- Filed
- January 11, 2022
- Registered
- Not yet
- Expires
- January 11, 2032
- Application no.
- Not recorded
- Registration no.
- 1702910
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 4 classes
Who owns BIOPROGNOSIS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Renalytix AI, Inc.
RNLXY · United States
Representative
Cooley LLP, Susan Piascik Christoff Cooley LLP
What the mark covers
The products and services BIOPROGNOSIS is filed for, grouped by Nice class.
Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing and disease prediction; medical diagnostic test strips; test strips for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health.
Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and medical sample tubes, vials for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health.
Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in the field of kidney, heart, and liver health and kidney, heart, and liver disease.
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease.
About BIOPROGNOSIS
Who owns the trademark "BIOPROGNOSIS"?
The WIPO trademark "BIOPROGNOSIS" is owned by Renalytix AI, Inc.
What is the status of "BIOPROGNOSIS"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull BIOPROGNOSIS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_e487e194-80c9-4373-bea6-8bc947dabac8
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_e487e194-80c9-4373-bea6-8bc947dabac8",
"object": "trademark",
"mark_text": "BIOPROGNOSIS",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2022-01-11",
"nice_classes": [
5,
10,
42,
44
],
"owners": [
{
"name": "RENALYTIX AI, INC.",
"entity_id": "ent_019ebbcd-e128-75cd-9acb-4e4bedf5d366"
}
]
}